Viewing nowCombinationTerium M Extended Release Tablet 10/750 mg
Metformin Hydrochloride 750mg · Teneligliptin Ditosylate Dihydrate 18.92mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.

MFDS item code 202202711 · Approved 2022.07.01 · Insurance code 657807720
Improves blood glucose control in type 2 diabetes
This medication is used to aid blood glucose control in patients with Type 2 diabetes suitable for the combined treatment of Teneligliptin and Metformin. It effectively helps manage blood sugar when combined with dietary and exercise therapies. In other words, this drug enhances blood glucose control alongside lifestyle improvements to assist in the treatment of Type 2 diabetes.
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000 mg extended-release tablet once daily. Patients taking the 10/750 mg or 10/500 mg extended-release tablets should take two tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching from concomitant therapy with teneligliptin and metformin to this medicine, treatment may be started at the doses of teneligliptin and metformin that the patient was previously taking. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and the dose adjusted as appropriate. When administered concomitantly with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20 mg and extended-release metformin 2000 mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering agents. Because changes may affect blood glucose control, any change in treatment for patients with type 2 diabetes should be made with careful monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.
This medication is used for the treatment of diabetes and assists in blood sugar control. There is a risk of developing a rare side effect known as lactic acidosis, which can occur when taking this medication, and caution is advised. Lactic acidosis is a condition where lactic acid accumulates excessively in the body, which can be dangerous and may pose a threat to life if left untreated. Patients with impaired kidney function, heart disease, acute infections, or severe trauma should not use this medication. Additionally, if you are scheduled for tests using radiographic contrast agents, you should discontinue this medication 48 hours prior to testing and resume only after confirming normal kidney function. It is also safest for pregnant women or women who may become pregnant, patients with impaired liver function, malnourished patients, or those who are dehydrated to avoid taking this medication. There may be an increased risk of hypoglycemia when used with other diabetes treatments, so it is important to be aware of the symptoms of hypoglycemia and how to respond to them. If unusual symptoms such as sudden abdominal pain, vomiting, severe fatigue, shortness of breath, or dizziness occur, you should consult a doctor immediately. This medication requires dosage adjustment based on kidney function, and regular kidney function tests should be performed, especially for elderly patients or those with reduced renal function. It is advised to avoid alcohol consumption during treatment, and regular blood tests are recommended as vitamin B12 levels may decrease. This medication is not recommended for breastfeeding women, and safety in pediatric patients has not been established. In case of overdose, seek immediate medical attention for appropriate treatment, and blood dialysis may be needed in some cases. Store this medication out of the reach of children and avoid transferring it to other containers. During treatment, it is necessary to periodically monitor liver function, kidney function, and blood glucose levels, and if any unusual symptoms occur, consult healthcare personnel immediately.
Severe lactic acidosis, severe hypoglycemia, hypoglycemia, constipation, intestinal obstruction, liver dysfunction, interstitial pneumonia, pemphigus vulgaris, acute pancreatitis, dizziness, abdominal distension, abdominal discomfort, nausea, abdominal pain, bloating, stomatitis, gastric polyps, colon polyps, duodenal ulcer, gastroesophageal reflux disease, diarrhea, appetite loss, elevated amylase, elevated lipase, elevated AST (GOT), elevated ALT (GPT), elevated GGT, elevated ALP, proteinuria, ketonuria, potential hematuria, eczema, rash, itching, allergic dermatitis, arthralgia, elevated CK (CPK), increased serum potassium concentration, fatigue, allergic rhinitis, elevated serum uric acid, peripheral edema, herpes zoster, limb pain, upper abdominal pain, gastritis, upper respiratory infection, tremor, headache, asthenia, hunger, fatigue, facial edema, dyspepsia, nausea, viral upper respiratory infection, rhinitis, clammy sweat, diabetic retinopathy, vision impairment, cough, pulmonary congestion, shortness of breath, drug overdose, benign prostatic hyperplasia, headache, diarrhea, chronic gastritis, irritable bowel syndrome, fatigue, cerebral infarction, hyperglycemia, liver biopsy, neutropenia, blood sugar abnormalities, increased blood glucose, increased blood pressure, hepatic coma, lumbar spinal stenosis, intervertebral disc protrusion in the spine, intervertebral disc disorder, spinal ligament ossification, spinal foraminal stenosis, rotator cuff syndrome, soft tissue infection, pneumonia, gastritis, vomiting, chronic gastritis, upper abdominal pain, stomatitis, gastrointestinal motility disorder, decreased gastrointestinal motility, enteritis, dental pain, anal rectal discomfort, acquired mixed hyperlipidemia, hypertriglyceridemia, vitamin D deficiency, abnormal weight gain, essential hypertension, orthostatic hypotension, white coat hypertension, iliac artery stenosis, bleeding, increased blood sugar, abnormal sputum, biliary obstruction, toxic hepatitis, chronic cholecystitis, non-alcoholic fatty liver disease, alcoholic liver disease, eyelid damage, ligament sprain, lip injury, bruise, urticaria, glaucoma, blurred vision, age-related macular degeneration, hyperthyroidism, hyperparathyroidism, coronary artery disease, unstable angina, angina pectoris, otalgia, vertigo, iron deficiency anemia, food allergy, pressure ulcer, hearing loss, endolymphatic hydrops, depression, insomnia, benign prostatic hyperplasia, ovarian cyst, vulvar pruritus, menopausal symptoms
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is best to maintain the storage temperature between 1 and 30 degrees Celsius at room temperature.
Yellow oval-shaped extended-release film-coated tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationMetformin Hydrochloride 750mg · Teneligliptin Ditosylate Dihydrate 18.92mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Teneligliptin Ditosylate Dihydrate 37.84mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationMetformin Hydrochloride 750mg · Teneligliptin Ditosylate Dihydrate 18.92mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Teneligliptin Ditosylate Dihydrate 18.92mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Teneligliptin Ditosylate Dihydrate 18.92mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Teneligliptin Ditosylate Dihydrate 37.84mg
Tablet · Prescription medication · Combination
Youngjin Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Teneligliptin Ditosylate Dihydrate 18.92mg
Tablet · Prescription medication · Combination
Youngjin Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 750mg · Teneligliptin Ditosylate Dihydrate 18.92mg
Tablet · Prescription medication · Combination
Youngjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.